Analysis of risk factors related to thyroid function abnormality caused by programmed death-1 inhibitors
ObjectiveTo investigate the clinical characteristics and influencing factors of thyroid function abnormality (TFA) in patients with malignant tumors receiving programmed death-1 (PD-1) inhibitor therapy, and its correlation with PD-1 inhibitors. MethodsA retrospective analysis was conducted on the c...
Saved in:
| Main Authors: | Lihong WANG, Huiyang SONG, Shufei ZANG, ling YE, Xuefei DANG |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shanghai Chinese Clinical Medicine Press Co., Ltd.
2025-08-01
|
| Series: | Zhongguo Linchuang Yixue |
| Subjects: | |
| Online Access: | https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20250550 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical manifestations and risk factors of immune-related thyroid adverse events in patients treated with PD-1 inhibitors: a case-control study
by: Pengfei Zhao, et al.
Published: (2025-04-01) -
Incidence of thyroid adverse events following immune checkpoint inhibitor treatment in patients with baseline positive thyroid antibodies: a systematic review and meta-analysis
by: Hui Yu, et al.
Published: (2025-07-01) -
Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors
by: Ichiro Yamauchi, et al.
Published: (2025-01-01) -
The impact of different types of radiotherapy on cerebrovascular-specific death in patients with thyroid malignant tumors
by: Xianghong Wang, et al.
Published: (2025-07-01) -
Immune checkpoint inhibitor-induced thyroiditis and its potential mechanisms
by: Xueqian Mao, et al.
Published: (2025-06-01)